Go Pro
→ They didn't warn anyone in 1971. This time someone is warning you. (From Reagan Gold Group) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
$5.60
-1.4%		$6.42
$5.21
▼
$13.43
$774.43M1.422.54 million shs1.73 million shs
Cosmos Health Inc. stock logo
COSM
Cosmos Health
$0.38
-1.6%		$0.26
$0.16
▼
$1.32
$38.86M4.683.70 million shs2.47 million shs
Wellgistics Health, Inc. stock logo
MEDS
Wellgistics Health
$3.68
-9.4%		$2.82
$0.82
▼
$73.00
$12.98M-3.5117.69 million shs1.15 million shs
111, Inc. Sponsored ADR stock logo
YI
111
$3.22
-2.7%		$3.57
$2.48
▼
$11.17
$29.04M0.6618,410 shs15,477 shs
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
-1.41%-0.71%-7.28%-47.96%-38.53%
Cosmos Health Inc. stock logo
COSM
Cosmos Health
-1.58%+8.08%+69.42%+60.27%-65.45%
Wellgistics Health, Inc. stock logo
MEDS
Wellgistics Health
-9.36%+18.33%+257.28%+23.49%-91.28%
111, Inc. Sponsored ADR stock logo
YI
111
-2.72%-15.60%-7.34%-22.03%-31.43%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
$5.60
-1.4%		$6.42
$5.21
▼
$13.43
$774.43M1.422.54 million shs1.73 million shs
Cosmos Health Inc. stock logo
COSM
Cosmos Health
$0.38
-1.6%		$0.26
$0.16
▼
$1.32
$38.86M4.683.70 million shs2.47 million shs
Wellgistics Health, Inc. stock logo
MEDS
Wellgistics Health
$3.68
-9.4%		$2.82
$0.82
▼
$73.00
$12.98M-3.5117.69 million shs1.15 million shs
111, Inc. Sponsored ADR stock logo
YI
111
$3.22
-2.7%		$3.57
$2.48
▼
$11.17
$29.04M0.6618,410 shs15,477 shs
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
-1.41%-0.71%-7.28%-47.96%-38.53%
Cosmos Health Inc. stock logo
COSM
Cosmos Health
-1.58%+8.08%+69.42%+60.27%-65.45%
Wellgistics Health, Inc. stock logo
MEDS
Wellgistics Health
-9.36%+18.33%+257.28%+23.49%-91.28%
111, Inc. Sponsored ADR stock logo
YI
111
-2.72%-15.60%-7.34%-22.03%-31.43%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
2.67
Moderate Buy$10.1481.12% Upside
Cosmos Health Inc. stock logo
COSM
Cosmos Health
1.00
SellN/AN/A
Wellgistics Health, Inc. stock logo
MEDS
Wellgistics Health
1.00
SellN/AN/A
111, Inc. Sponsored ADR stock logo
YI
111
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest AHCO, COSM, YI, and MEDS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/28/2026
111, Inc. Sponsored ADR stock logo
YI
111
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
9/21/2026
Wellgistics Health, Inc. stock logo
MEDS
Wellgistics Health
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
9/17/2026
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
Robert W. Baird logo
Robert W. Baird
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOutperform$10.00 ➝ $9.00
8/31/2026
111, Inc. Sponsored ADR stock logo
YI
111
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
8/19/2026
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D)
8/14/2026
111, Inc. Sponsored ADR stock logo
YI
111
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
8/6/2026
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$14.00 ➝ $10.00
8/6/2026
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
Royal Bank Of Canada logo
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOutperform$15.00 ➝ $8.00
8/5/2026
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
Truist Financial Corporation logo
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$14.00 ➝ $9.00
8/5/2026
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
Robert W. Baird logo
Robert W. Baird
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$10.00
8/5/2026
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
Canaccord Genuity Group Inc. logo
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$10.00
(Data available from 10/3/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
$3.35B0.23$4.12 per share1.36$11.27 per share0.50
Cosmos Health Inc. stock logo
COSM
Cosmos Health
$73.73M0.52N/AN/A$0.45 per share0.84
Wellgistics Health, Inc. stock logo
MEDS
Wellgistics Health
$23.34M0.50N/AN/A($6.94) per share-0.53
111, Inc. Sponsored ADR stock logo
YI
111
$10.48B0.00N/AN/A($11.74) per share-0.27
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
-$70.79M-$1.71N/AN/AN/A-7.07%3.36%1.16%11/3/2026 (Estimated)
Cosmos Health Inc. stock logo
COSM
Cosmos Health
-$19.15M-$0.64N/A5.43N/A-33.08%-56.88%-18.03%11/13/2026 (Estimated)
Wellgistics Health, Inc. stock logo
MEDS
Wellgistics Health
-$101.28M-$46.13N/AN/AN/A-1,100.16%N/A-171.81%N/A
111, Inc. Sponsored ADR stock logo
YI
111
-$9.65M-$1.60N/AN/AN/A-1.01%N/A-4.86%11/26/2026 (Estimated)

Latest AHCO, COSM, YI, and MEDS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
9/18/2026Q2 2026
111, Inc. Sponsored ADR stock logo
YI
111
N/A-$0.60N/A-$0.65N/A$338.55 million
8/19/2026Q2 2026
Cosmos Health Inc. stock logo
COSM
Cosmos Health
-$0.10-$0.10N/A-$0.10$18.99 million$19.32 million
8/17/2026Q2 2026
Wellgistics Health, Inc. stock logo
MEDS
Wellgistics Health
N/A-$7.13N/A-$7.13N/A$1.78 million
8/4/2026Q2 2026
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
$0.1688-$0.99-$1.1588-$0.99$846.77 million$740.31 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
N/AN/AN/AN/AN/A
Cosmos Health Inc. stock logo
COSM
Cosmos Health
N/AN/AN/AN/AN/A
Wellgistics Health, Inc. stock logo
MEDS
Wellgistics Health
N/AN/AN/AN/AN/A
111, Inc. Sponsored ADR stock logo
YI
111
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
1.37
1.12
0.98
Cosmos Health Inc. stock logo
COSM
Cosmos Health
0.15
1.05
0.92
Wellgistics Health, Inc. stock logo
MEDS
Wellgistics Health
N/A
0.14
0.10
111, Inc. Sponsored ADR stock logo
YI
111
N/A
1.08
0.49

Institutional Ownership

CompanyInstitutional Ownership
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
82.67%
Cosmos Health Inc. stock logo
COSM
Cosmos Health
12.61%
Wellgistics Health, Inc. stock logo
MEDS
Wellgistics Health
5.68%
111, Inc. Sponsored ADR stock logo
YI
111
21.32%

Insider Ownership

CompanyInsider Ownership
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
1.95%
Cosmos Health Inc. stock logo
COSM
Cosmos Health
26.15%
Wellgistics Health, Inc. stock logo
MEDS
Wellgistics Health
29.10%
111, Inc. Sponsored ADR stock logo
YI
111
43.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
10,900136.34 million133.69 millionOptionable
Cosmos Health Inc. stock logo
COSM
Cosmos Health
163100.63 million74.32 millionOptionable
Wellgistics Health, Inc. stock logo
MEDS
Wellgistics Health
313.20 million2.27 millionN/A
111, Inc. Sponsored ADR stock logo
YI
111
1,0638.79 million4.93 millionOptionable

Recent News About These Companies

111, Inc. Announces Establishment of Special Committee
September 28, 2026  |  marketscreener.comM
111 Forms Special Committee To Review Takeover Proposal And Strategic Options
September 28, 2026  |  rttnews.comhttps://www.rttnews.com/3694256/111-forms-special-committee-to-review-takeover-proposal-and-strategic-options.aspx
111, Inc. Announces Establishment of the Special Committee
September 28, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/111-inc-announces-establishment-of-the-special-committee-302891226.html
111, Inc Q2 Loss Widens From Lower Revenue; Shares Up
September 17, 2026  |  rttnews.comhttps://www.rttnews.com/3692015/111-inc-q2-loss-widens-from-lower-revenue-shares-up.aspx
111, Inc. Posts Q2'26 Results As Asset-Light Shifts Lowers Revenue But Improved Efficiency; Stock Up
September 17, 2026  |  rttnews.comhttps://www.rttnews.com/3691857/111-inc-posts-q2-26-results-as-asset-light-shifts-lowers-revenue-but-improved-efficiency-stock-up.aspx
111 Receives Going-Private Proposal From Co-Founders, Huadeng Tech BioArray Ventures
September 17, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/111-receives-going-private-proposal-090107896.html
111 Inc. Receives Unsolicited Preliminary Non-Binding Proposal to Acquire the Company
September 17, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/111-inc-receives-unsolicited-preliminary-non-binding-proposal-to-acquire-the-company-302881784.html
111, Inc. Announces Second Quarter 2026 Unaudited Financial Results
September 17, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/111-inc-announces-second-quarter-2026-unaudited-financial-results-302881371.html
Critical Review: 111 (NASDAQ:YI) and SBC Medical Group (NASDAQ:SBC)
September 16, 2026  |  defenseworld.netD
111 Inc. ADR
August 25, 2026  |  barrons.comhttps://www.barrons.com/market-data/stocks/yi/company-people
Yang Luke Chen Sells 44,000 Shares of 111 (NASDAQ:YI) Stock
June 17, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-yi-insider-buying-and-selling-2026-06-17/
111, Inc. Sponsored ADR
June 13, 2026  |  edition.cnn.comhttps://edition.cnn.com/markets/stocks/YI
111 (NASDAQ:YI) Director Jian David Sun Sells 111,100 Shares
June 13, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-yi-insider-buying-and-selling-2026-06-13/
111 (NASDAQ:YI) Director Jian David Sun Sells 115,440 Shares
June 12, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-yi-insider-buying-and-selling-2026-06-12/
111: Q1 Earnings Snapshot
June 4, 2026  |  khou.comK
111, Inc. Announces First Quarter 2026 Unaudited Financial Results
June 4, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/111-inc-announces-first-quarter-2026-unaudited-financial-results-302791140.html
Jian David Sun Sells 70,440 Shares of 111 (NASDAQ:YI) Stock
May 30, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-yi-insider-buying-and-selling-2026-05-30/
111: Q4 Earnings Snapshot
April 9, 2026  |  khou.comK
111, Inc. Announces Fourth Quarter and Fiscal Year 2025 Financial Results
April 9, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/111-inc-announces-fourth-quarter-and-fiscal-year-2025-financial-results-302737785.html
111: Q3 Earnings Snapshot
December 18, 2025  |  khou.comK

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Autonomous military drone with AV-style logo on the nose sitting on a runway, representing AeroVironment and the defense drone industry.
AeroVironment's Record Backlog and Earnings Beat Fuel Recovery Case
By Thomas Hughes | September 10, 2026
Stacks of US currency and an official document sit on a desk in a government chamber.
3 Stocks to Buy and Hold for Higher Interest Rates
By Thomas Hughes | September 9, 2026
Large haul trucks travel a winding road through an open-pit mine at sunrise or sunset.
Bond Yields Are Pressuring Gold, But Miners May Tell a Different Story
By Jeffrey Neal Johnson | September 8, 2026
Laptop displaying a U.S. Treasury yield curve chart on a desk with monitors showing stock market data.
3 ETFs That Could Move as Rate Expectations Shift
By Dan Schmidt | September 6, 2026
Enterprise Products, Energy Transfer and Williams: 3 AI Power Bottleneck Plays
The AI Bottleneck Is Not Chips Anymore and 3 Pipeline Stocks Are Cashing In
By Bridget Bennett | September 20, 2026
AdaptHealth stock logo

AdaptHealth NASDAQ:AHCO

$5.60 -0.08 (-1.41%)
Closing price 10/2/2026 04:00 PM Eastern
Extended Trading
$5.60 0.00 (0.00%)
As of 10/2/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also offers wheelchairs, hospital beds, oxygen concentrators, CPAP masks and related supplies, wound care supplies, diabetes management supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.

Cosmos Health stock logo

Cosmos Health NASDAQ:COSM

$0.38 -0.01 (-1.58%)
Closing price 10/2/2026 04:00 PM Eastern
Extended Trading
$0.38 +0.00 (+0.53%)
As of 10/2/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors. It sells its products through independent wholesale distributors. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.

Wellgistics Health stock logo

Wellgistics Health NASDAQ:MEDS

$3.68 -0.38 (-9.36%)
As of 10/2/2026 04:00 PM Eastern

Founded in 2022, Wellgistics Health is a holding company for various existing and planned strategic businesses centered around pharmaceuticals and healthcare services. As a micro health ecosystem, our portfolio of companies consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services. We are focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. In January 2023 and May 2023, Wellgistics Health entered into separate definitive agreements with the owners of Wood Sage and Wellgistics LLC, respectively, whereby Wellgistics Health would acquire all of the respective outstanding membership interests of Wood Sage and Wellgistics LLC. In June 2024, Wellgistics Health and Wood Sage entered into an amended and revised definitive agreement and closed on the Wood Sage Acquisition, thereby making Wood Sage a wholly owned subsidiary of Wellgistics Health. In connection with the Wood Sage Acquisition, Wellgistics Health acquired Wood Sage’s two operating subsidiaries, APS—a pharmaceutical technology hub—and CSP—a retail community specialty pharmacy. On August 30, 2024, Wellgistics Health closed on the Wellgistics Acquisition, thereby making Wellgistics LLC—a company focused on wholesale operations including the distribution and fulfillment of certain pharmaceutical medications to a network of independent pharmacies meant to improve market access to and patient outcomes regarding the medications—a wholly owned subsidiary of Wellgistics Health. As such, Wellgistics Health currently exists as a holding company with Wood Sage as a directly held intermediate holding company subsidiary, APS and CSP as indirect operating subsidiaries, and Wellgistics LLC as a direct operating subsidiary. On October 4, 2024, the Company changed its corporate name to “Wellgistics Health, Inc.” by filing a duly authorized Certificate of Amendment to its Certificate of Incorporation. Despite that Wellgistics Health only recently closed the Wood Sage Acquisition and the Wellgistics Acquisition during 2024, the three companies have shared common office space, comarketed solutions to the marketplace, and leveraged financial and back-office support prior to June 2024. As such, Wellgistics Health’s management believes that its close business relationships have and will continue to limit the need for post-closing integration. The mailing address of our principal executive office is 3000 Bayport Drive, Suite 950 Tampa, FL.

111 stock logo

111 NASDAQ:YI

$3.22 -0.09 (-2.72%)
Closing price 10/2/2026 03:59 PM Eastern
Extended Trading
$3.22 0.00 (0.00%)
As of 10/2/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

111, Inc. engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies. The B2B segment includes the sale of pharmaceutical products to pharmacy customers through 1 Drug Mall. The company was founded by Gang Yu and Jun Ling Liu in May 2013 and is headquartered in Shanghai, China.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas